Related content

Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma

By Santoni Matteo  

Journal of Neuro-Oncology, Vol. 113, Iss. 3, 2013-07 ,pp. : 397-401

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan

By Zuniga R.   Torcuator R.   Jain R.   Anderson J.   Doyle T.   Ellika S.   Schultz L.   Mikkelsen T.  

Journal of Neuro-Oncology, Vol. 91, Iss. 3, 2009-02 ,pp. : 329-336

Springer Publishing Company

Access to resources Recommend Favorite

Japanese experience with second-line chemotherapy with low-dose (60 mg/m) docetaxel in patients with advanced non-small-cell lung cancer

By Mukohara Toru   Takeda Koji   Miyazaki Masaki   Takifuji Nobuhide   Terakawa Kazuhiko   Negoro Shunichi  

Cancer Chemotherapy and Pharmacology, Vol. 48, Iss. 5, 2001-11 ,pp. : 356-360

Springer Publishing Company

Access to resources Recommend Favorite

Two- vs three-drug combination chemotherapy in advanced or recurrent head and neck cancer: A single institution experience of 361 patients

By Pai V.   Mazumdar T.   Deshmukh C.   Bakshi A.   Parikh D.   Parikh P.   Mistry R.   Pathak K.   D’Cruz A.  

Medical Oncology, Vol. 21, Iss. 4, 2004-12 ,pp. : 305-308

Humana Press, Inc

Access to resources Recommend Favorite

The Effectiveness of S-1 Based Sequential Chemotherapy as Second-Line Treatment for Advanced/Recurrent Gastric Cancer

By Sugimoto Naotoshi   Narahara Hiroyuki   Sakai Daisuke   Yamamoto Sachiko   Fumoto Shoichi   Yagi Toshinari   Imamura Fumio   Iishi Hiroyasu   Tatsuta Masaharu  

Japanese Journal of Cancer and Chemotherapy, Vol. 36, Iss. 3, 2009-03 ,pp. : 417-424

Sunmedia

Access to resources Recommend Favorite